Cargando…
Molecular characteristics of eae-positive clinical Shiga toxin-producing Escherichia coli in Sweden
Shiga toxin (Stx)-producing Escherichia coli (STEC) can cause a wide range of symptoms from asymptomatic carriage, mild diarrhea to bloody diarrhea (BD) and hemolytic uremic syndrome (HUS). Intimin, encoded by the eae gene, also plays a critical role in STEC pathogenesis. Herein, we investigated the...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733975/ https://www.ncbi.nlm.nih.gov/pubmed/33179570 http://dx.doi.org/10.1080/22221751.2020.1850182 |
_version_ | 1783622373865422848 |
---|---|
author | Hua, Ying Bai, Xiangning Zhang, Ji Jernberg, Cecilia Chromek, Milan Hansson, Sverker Frykman, Anne Yang, Xi Xiong, Yanwen Wan, Chengsong Matussek, Andreas |
author_facet | Hua, Ying Bai, Xiangning Zhang, Ji Jernberg, Cecilia Chromek, Milan Hansson, Sverker Frykman, Anne Yang, Xi Xiong, Yanwen Wan, Chengsong Matussek, Andreas |
author_sort | Hua, Ying |
collection | PubMed |
description | Shiga toxin (Stx)-producing Escherichia coli (STEC) can cause a wide range of symptoms from asymptomatic carriage, mild diarrhea to bloody diarrhea (BD) and hemolytic uremic syndrome (HUS). Intimin, encoded by the eae gene, also plays a critical role in STEC pathogenesis. Herein, we investigated the prevalence and genetic diversity of eae among clinical STEC isolates from patients with diarrhea, BD, HUS as well as from asymptomatic STEC-positive individuals in Sweden with whole-genome sequencing. We found that 173 out of 239 (72.4%) of clinical STEC strains were eae positive. Six eae subtypes (ϵ1, γ1, β3, θ, ζ and ρ) were identified eae and its subtype γ1 were significantly overrepresented in O157:H7 strains isolated from BD and HUS patients. ϵ1 was associated with O121:H19 and O103:H2 strains, and β3 to O26:H11 strains. The combination of eae subtype γ1 and stx subtype (stx(2) or stx(1)+stx(2)) is more likely to cause severe disease, suggesting the possibility of using eae genotypes in risk assessment of STEC infection. In summary, this study demonstrated a high prevalence of eae in clinical STEC strains and considerable genetic diversity of eae in STEC strains in Sweden from 1994 through 2018, and revealed association between eae subtypes and disease severity. |
format | Online Article Text |
id | pubmed-7733975 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-77339752020-12-18 Molecular characteristics of eae-positive clinical Shiga toxin-producing Escherichia coli in Sweden Hua, Ying Bai, Xiangning Zhang, Ji Jernberg, Cecilia Chromek, Milan Hansson, Sverker Frykman, Anne Yang, Xi Xiong, Yanwen Wan, Chengsong Matussek, Andreas Emerg Microbes Infect Research Article Shiga toxin (Stx)-producing Escherichia coli (STEC) can cause a wide range of symptoms from asymptomatic carriage, mild diarrhea to bloody diarrhea (BD) and hemolytic uremic syndrome (HUS). Intimin, encoded by the eae gene, also plays a critical role in STEC pathogenesis. Herein, we investigated the prevalence and genetic diversity of eae among clinical STEC isolates from patients with diarrhea, BD, HUS as well as from asymptomatic STEC-positive individuals in Sweden with whole-genome sequencing. We found that 173 out of 239 (72.4%) of clinical STEC strains were eae positive. Six eae subtypes (ϵ1, γ1, β3, θ, ζ and ρ) were identified eae and its subtype γ1 were significantly overrepresented in O157:H7 strains isolated from BD and HUS patients. ϵ1 was associated with O121:H19 and O103:H2 strains, and β3 to O26:H11 strains. The combination of eae subtype γ1 and stx subtype (stx(2) or stx(1)+stx(2)) is more likely to cause severe disease, suggesting the possibility of using eae genotypes in risk assessment of STEC infection. In summary, this study demonstrated a high prevalence of eae in clinical STEC strains and considerable genetic diversity of eae in STEC strains in Sweden from 1994 through 2018, and revealed association between eae subtypes and disease severity. Taylor & Francis 2020-12-10 /pmc/articles/PMC7733975/ /pubmed/33179570 http://dx.doi.org/10.1080/22221751.2020.1850182 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Hua, Ying Bai, Xiangning Zhang, Ji Jernberg, Cecilia Chromek, Milan Hansson, Sverker Frykman, Anne Yang, Xi Xiong, Yanwen Wan, Chengsong Matussek, Andreas Molecular characteristics of eae-positive clinical Shiga toxin-producing Escherichia coli in Sweden |
title | Molecular characteristics of eae-positive clinical Shiga toxin-producing Escherichia coli in Sweden |
title_full | Molecular characteristics of eae-positive clinical Shiga toxin-producing Escherichia coli in Sweden |
title_fullStr | Molecular characteristics of eae-positive clinical Shiga toxin-producing Escherichia coli in Sweden |
title_full_unstemmed | Molecular characteristics of eae-positive clinical Shiga toxin-producing Escherichia coli in Sweden |
title_short | Molecular characteristics of eae-positive clinical Shiga toxin-producing Escherichia coli in Sweden |
title_sort | molecular characteristics of eae-positive clinical shiga toxin-producing escherichia coli in sweden |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733975/ https://www.ncbi.nlm.nih.gov/pubmed/33179570 http://dx.doi.org/10.1080/22221751.2020.1850182 |
work_keys_str_mv | AT huaying molecularcharacteristicsofeaepositiveclinicalshigatoxinproducingescherichiacoliinsweden AT baixiangning molecularcharacteristicsofeaepositiveclinicalshigatoxinproducingescherichiacoliinsweden AT zhangji molecularcharacteristicsofeaepositiveclinicalshigatoxinproducingescherichiacoliinsweden AT jernbergcecilia molecularcharacteristicsofeaepositiveclinicalshigatoxinproducingescherichiacoliinsweden AT chromekmilan molecularcharacteristicsofeaepositiveclinicalshigatoxinproducingescherichiacoliinsweden AT hanssonsverker molecularcharacteristicsofeaepositiveclinicalshigatoxinproducingescherichiacoliinsweden AT frykmananne molecularcharacteristicsofeaepositiveclinicalshigatoxinproducingescherichiacoliinsweden AT yangxi molecularcharacteristicsofeaepositiveclinicalshigatoxinproducingescherichiacoliinsweden AT xiongyanwen molecularcharacteristicsofeaepositiveclinicalshigatoxinproducingescherichiacoliinsweden AT wanchengsong molecularcharacteristicsofeaepositiveclinicalshigatoxinproducingescherichiacoliinsweden AT matussekandreas molecularcharacteristicsofeaepositiveclinicalshigatoxinproducingescherichiacoliinsweden |